Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pediatrix Medical Group (MD)
NYSE:MD
Holding MD?
Track your performance easily
MD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.62 - $16.41
Previous CloseN/A
Volume66.51K
Average Volume (3M)695.86K
Market Cap
$1.23B
Enterprise Value$1.44B
Total Cash (Recent Filing)$66.98M
Total Debt (Recent Filing)$1.68B
Price to Earnings (P/E)―
Beta0.26
Next Earnings
Feb 13, 2025EPS Estimate
0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.06
Shares Outstanding85,880,486
10 Day Avg. Volume532,144
30 Day Avg. Volume695,860
Standard Deviation0.16
R-Squared0.29
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.61
Price to Cash Flow (P/CF)3.40
P/FCF Ratio3.60
Enterprise Value/Market Cap1.17
Enterprise Value/Revenue0.72
Enterprise Value/Gross Profit3.42
Enterprise Value/Ebitda4.62
Forecast
1Y Price Target
$16.07Price Target Upside11.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Pediatrix Medical Group News
PremiumCompany Announcements
Pediatrix Medical Group Appoints New CEO Mark S. Ordan
PremiumCompany Announcements
Pediatrix Medical Group Appoints New CEO Amidst Strategy Shift
PremiumCompany Announcements
Pediatrix Announces Leadership Transition of Dr. PickertBulls Say, Bears Say
Bulls Say
Financial Performance2024 EBITDA now expected to be at or above the high-end of the company's targets.
Operational EfficiencyManagement expects the disposition of the unprofitable pediatric urgent care clinics business to generate $30m EBITDA accretion and reduce capital intensity.
Revenue GrowthCommercial payer mix now represents 72% of total revenue compared to 67% in 3Q23, which is largely contributing to the strong performance.
Bears Say
Business PerformanceIn the absence of improving payer mix, the business performance was very much mixed, with potential for further deceleration in core/organic EBITDA.
Leadership ChangeCEO James Swift will step down and Chairman Mark Ordan will reassume the role of CEO, with little commentary on the abrupt transition.
Revenue ImpactThe company is expecting a $200 million negative revenue impact from planned divestitures of certain practices and facilities.
---
Ownership Overview
1.49% Insiders
28.87% Mutual Funds
0.36% Other Institutional Investors
37.53% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MD FAQ
What was Pediatrix Medical Group’s price range in the past 12 months?
Pediatrix Medical Group lowest stock price was $6.62 and its highest was $16.41 in the past 12 months.
What is Pediatrix Medical Group’s market cap?
Pediatrix Medical Group’s market cap is $1.23B.
When is Pediatrix Medical Group’s upcoming earnings report date?
Pediatrix Medical Group’s upcoming earnings report date is Feb 13, 2025 which is in 14 days.
How were Pediatrix Medical Group’s earnings last quarter?
Pediatrix Medical Group released its earnings results on Nov 01, 2024. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.368 by $0.072.
Is Pediatrix Medical Group overvalued?
According to Wall Street analysts Pediatrix Medical Group’s price is currently Undervalued.
Does Pediatrix Medical Group pay dividends?
Pediatrix Medical Group does not currently pay dividends.
What is Pediatrix Medical Group’s EPS estimate?
Pediatrix Medical Group’s EPS estimate is 0.37.
How many shares outstanding does Pediatrix Medical Group have?
Pediatrix Medical Group has 85,880,486 shares outstanding.
What happened to Pediatrix Medical Group’s price movement after its last earnings report?
Pediatrix Medical Group reported an EPS of $0.44 in its last earnings report, beating expectations of $0.368. Following the earnings report the stock price went up 23.458%.
Which hedge fund is a major shareholder of Pediatrix Medical Group?
Among the largest hedge funds holding Pediatrix Medical Group’s share is Caspian Capital LP. It holds Pediatrix Medical Group’s shares valued at 13M.
---
Pediatrix Medical Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$16.07 (11.13% Upside)
$16.07 (11.13% Upside)
Hedge Fund Trend
Increased
By 557.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $553.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 4.7%
Last 30 Days ▲ 4.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.54%
12-Months-Change
Fundamentals
Return on Equity
-29.85%
Trailing 12-Months
Asset Growth
-10.72%
Trailing 12-Months
Company Description
Pediatrix Medical Group
MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company's solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. MEDNAX was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
---
MD Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a company undergoing significant operational changes with modest revenue growth and successful completion of strategic initiatives like the hybrid revenue cycle management transition. However, the impact of portfolio restructuring and increased G&A expenses present challenges. The sentiment is balanced between strategic progress and operational hurdles.Read More>---
MD Stock 12 Month Forecast
Average Price Target
$16.07
▲(11.13% Upside)
Technical Analysis
Acadia Healthcare
―
Community Health
―
HCA Healthcare
―
Tenet Healthcare
―
Universal Health
―
Best Analysts Covering MD
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
-0.53%
reiterated a sell rating 9 months ago
Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -0.53% per trade.
---